[go: up one dir, main page]

HK1223297A1 - 外用类维生素a溶液 - Google Patents

外用类维生素a溶液 Download PDF

Info

Publication number
HK1223297A1
HK1223297A1 HK16111649.4A HK16111649A HK1223297A1 HK 1223297 A1 HK1223297 A1 HK 1223297A1 HK 16111649 A HK16111649 A HK 16111649A HK 1223297 A1 HK1223297 A1 HK 1223297A1
Authority
HK
Hong Kong
Prior art keywords
composition
isotretinoin
composition according
pharmaceutically acceptable
topical
Prior art date
Application number
HK16111649.4A
Other languages
English (en)
Inventor
Sanjay Kumar Motwani
Shashikanth P. Isloor
Vinod Arora
Original Assignee
Sun Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Limited filed Critical Sun Pharmaceutical Industries Limited
Publication of HK1223297A1 publication Critical patent/HK1223297A1/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203—Retinoic acids ; Salts thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
HK16111649.4A 2009-05-20 2016-10-07 外用类维生素a溶液 HK1223297A1 (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
INDE10392009 2009-05-20
IN1039DE2009 2009-05-20
IN2759DE2009 2009-12-31
INDE27592009 2009-12-31

Publications (1)

Publication Number Publication Date
HK1223297A1 true HK1223297A1 (zh) 2017-07-28

Family

ID=54258969

Family Applications (1)

Application Number Title Priority Date Filing Date
HK16111649.4A HK1223297A1 (zh) 2009-05-20 2016-10-07 外用类维生素a溶液

Country Status (9)

Country Link
US (1) US10123970B2 (zh)
EP (2) EP3006021A1 (zh)
CN (1) CN102458362A (zh)
BR (1) BRPI1010972A2 (zh)
CA (1) CA2762394C (zh)
HK (1) HK1223297A1 (zh)
MX (1) MX2011012233A (zh)
SG (2) SG2014012173A (zh)
WO (1) WO2010134048A2 (zh)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015023497A1 (en) * 2013-08-13 2015-02-19 Access Business Group International Llc Use of fatty acid to reduce skin irritation associated with retinoid therapy
US10933018B2 (en) 2015-10-30 2021-03-02 Timber Pharmaceuticals Llc Isotretinoin formulations and uses and methods thereof
EP3554469A1 (en) 2016-12-13 2019-10-23 The Procter and Gamble Company Stable personal care compositions containing a retinoid
US20230143793A1 (en) * 2020-04-02 2023-05-11 Twinmedix Llc Cosmetic compositions
CN119033671B (zh) * 2024-09-05 2025-04-04 中南大学湘雅三医院 一种异维a酸油剂及其制备方法和应用

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT331797B (de) 1973-03-01 1976-08-25 Wuelfing J A Fa Verfahren zur herstellung des neuen 1,3-bis- (beta-athylhexyl)-5-amino-5-methyl-hexahydropyrimidin-pyridin-3-carboxylats
US4322438A (en) 1979-08-06 1982-03-30 United States Of America Method for the use of orally administered 13-cis-retinoic acid in the treatment of acne
US4593046A (en) 1983-07-15 1986-06-03 Murray Gruber Method of reducing skin irritation from benzoyl peroxide
US4678663A (en) * 1984-02-06 1987-07-07 Nuetrogena Corporation Hydroquinone composition having enhanced bio-availability and percutaneous adsorption
US4888342A (en) 1984-05-16 1989-12-19 Kligman Albert M Methods for treatment of sundamaged human skin with retinoids
CA1282326C (en) 1984-12-14 1991-04-02 Paul J. Jarosz Pharmaceutical composition containing 13-cis vitamin a acid as the active ingredient
CA2063576C (en) 1989-06-07 1994-01-25 Gail S. Bazzano Slow release vehicles for minimizing skin irritancy of topical compositions
AU670777B2 (en) 1992-04-16 1996-08-01 Ortho Pharmaceutical Corporation Aqueous gel vehicles for retinoids
US5252604A (en) 1992-07-10 1993-10-12 Hoffmann-La Roche Inc. Compositions of retinoic acids and tocopherol for prevention of dermatitis
US6503523B2 (en) * 1998-05-07 2003-01-07 Gs Development A.B. Skin care agents containing combinations of active agents consisting of vitamin a derivatives and UBI- or plastoquinones
PE20001227A1 (es) 1998-10-30 2000-11-06 Hoffmann La Roche Procesos para producir una composicion de isotretinoina
US6248354B1 (en) * 1999-03-04 2001-06-19 Allergan Sales, Inc. Capsule system
US6277881B1 (en) 1999-05-27 2001-08-21 Unilever Home & Personal Care, Usa, Division Of Conopco, Inc. Turmeric as an anti-irritant in compositions containing hydroxy acids or retinoids
US6339107B1 (en) 2000-08-02 2002-01-15 Syntex (U.S.A.) Llc Methods for treatment of Emphysema using 13-cis retinoic acid
RU2168996C1 (ru) 2000-09-19 2001-06-20 Фармацевтическое научно-производственное предприятие "Ретиноиды" (акционерное общество закрытого типа) Стабильный раствор ретинола пальмитата и способ лечения заболеваний кожи
US7435427B2 (en) 2000-09-22 2008-10-14 Galephar M/F Pharmaceutical semi-solid composition of isotretinoin
FR2818905A1 (fr) 2000-12-28 2002-07-05 Cll Pharma Compositions pharmaceutiques colloidales micellaires renfermant un principe actif lipophile
US7211267B2 (en) * 2001-04-05 2007-05-01 Collagenex Pharmaceuticals, Inc. Methods of treating acne
BR0117191A (pt) * 2001-12-06 2005-05-10 Ranbaxy Lab Ltd Composições nanoparticuladas de isotretinoina
GB0307864D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US20050009910A1 (en) 2003-07-10 2005-01-13 Allergan, Inc. Delivery of an active drug to the posterior part of the eye via subconjunctival or periocular delivery of a prodrug
FR2870125B1 (fr) * 2004-05-12 2010-03-26 Dermaconcept Jmc Formulation du type spot-on utile en cosmetologie et en dermatologie
US20060177392A1 (en) * 2005-02-10 2006-08-10 William Walden Oil-based composition for acne
US20060241078A1 (en) * 2005-03-16 2006-10-26 Ahmed Salah U Pharmaceutical compositions comprising a contraceptive agent in solution and a teratogen
JP2009513642A (ja) 2005-10-25 2009-04-02 アボット・ラボラトリーズ 低水溶解度の薬剤を含む製剤およびそれの使用方法
CN101066340B (zh) * 2007-05-16 2012-06-27 苏振芳 复方外用河豚毒素油膏及其制备方法
WO2010008600A1 (en) 2008-07-16 2010-01-21 Dermworx Incorporated Topical drug delivery system
US20120259013A1 (en) 2009-05-20 2012-10-11 Ranbaxy Laboratories Limited Liquid dosage forms of isotretinoin

Also Published As

Publication number Publication date
MX2011012233A (es) 2012-04-19
EP2432453A2 (en) 2012-03-28
WO2010134048A2 (en) 2010-11-25
BRPI1010972A2 (pt) 2019-04-16
CA2762394A1 (en) 2010-11-25
WO2010134048A3 (en) 2012-01-12
CN102458362A (zh) 2012-05-16
EP3006021A1 (en) 2016-04-13
US20120259014A1 (en) 2012-10-11
SG176097A1 (en) 2011-12-29
US10123970B2 (en) 2018-11-13
CA2762394C (en) 2016-07-19
SG2014012173A (en) 2014-07-30

Similar Documents

Publication Publication Date Title
AU778524B2 (en) Anhydrous topical skin preparations
Tanghetti et al. A current review of topical benzoyl peroxide: new perspectives on formulation and utilization
US20080194664A1 (en) Avermectin/metronidazole compositions for treating afflictions of the skin, e.g., rosacea
WO2012015487A1 (en) Combination of dapsone with adapalene
EP3030229B1 (en) Anti-acne compositions comprising bile acid-fatty acid conjugates
WO2011014627A1 (en) Combination of dapsone with adapalene
HK1223297A1 (zh) 外用类维生素a溶液
US20040157936A1 (en) Anhydrous topical skin preparations
WO2009116086A2 (en) Stable fixed dose topical formulation
US20110305747A1 (en) Combination of dapsone with other anti-acne agents
WO2008092911A1 (en) Use of adapalene and benzoyl peroxide for the long term treatment of acne vulgaris
CN1972708A (zh) 用于局部治疗的组合物
US10022348B2 (en) Topical solution of isotretinoin
EP2838508A1 (en) Formulations and methods for treatment of acne and inflammatory skin conditions
Bowe et al. Solodyn and updates on topical and oral therapies for acne
US9642877B1 (en) Method of administration of chromium and magnesium sulfate for treatment of acne
WO2024263134A1 (en) Safe and effective drug formulation used for the treatment of psoriasis
Naudé Formulation, in vitro release and transdermal diffusion of Vitamin A and Zinc for the treatment of acne
WO2021189077A1 (en) Methods for treating acne
EP1159956A2 (en) Anhydrous topical skin preparations
CA2963110A1 (en) Method of administration of chromium and magnesium sulfate for treatment of acne
Sharma Topical approach expresses high level of potential in Acne
Gold Novel AHA-Retinoid Ester in Combination with Salicylic Acid for the Treatment of Acne
MXPA00007720A (en) Anhydrous topical skin preparations
TW201536335A (zh) 脂肪酸於減少與類視色素治療相關之皮膚刺激的用途